Gout medications are a common part of the treatment for people with type 1 diabetes.
A recent study in the Journal of the American Medical Association suggested that people taking the medications may be at increased risk for developing high blood pressure and heart attacks, as well as diabetes.
But a new study in The Lancet Diabetes & Endocrinology published online Monday suggests that some of the medications used in the diabetes drug class may not be safe and could increase the risk for death or serious complications, especially among those with high blood sugar levels.
“There’s evidence that the prescribing of these medications may lead to adverse events such as an increase in blood pressure, cardiac arrhythmias, and sudden death, and that these are potentially life-threatening consequences,” said Dr. Jules Van de Ven, an associate professor at the University of California, San Francisco.
“And it’s a risk that we really need to be aware of.”
The authors of the study said that they wanted to determine whether the drugs they were looking at were actually effective.
They took blood samples from 12 patients with type 2 diabetes who were given three different types of gout medications: gout-stimulant tablets, a common medication for people living with the condition; a placebo, or a drug used to treat people with the disease without the condition.
In all, the study examined 24 people with Type 2 diabetes.
All were treated for the disease in the hospital.
All of the patients had a high blood glucose level and had an increased risk of developing type 2.
The patients were given gout drugs, such as gout pill, as a treatment for the condition, according to the study.
The patients were followed over the course of a year, and the researchers used a statistical analysis to compare the patients’ glucose levels at the end of the year and at the beginning of the next year.
“We found that the incidence of serious cardiovascular events was significantly higher in those who received gout tablets than in those treated with the placebo,” said Van de V, who also serves as a consultant for the U.S. Centers for Disease Control and Prevention’s National Heart, Lung and Blood Institute.
The researchers say this could be a sign of a serious underlying health problem, such that gout pills could actually lead to a life-long increase in risk of cardiovascular events.
In the study, the researchers found that there were significant increases in blood glucose levels in people who received the gout drug over the two years.
They also found that some patients had serious health complications, such heart failure, strokes, and death.
The study authors say that this could indicate that the medications were causing the adverse effects, and they are calling for a review of the current prescribing guidelines for these medications.